IDH1 and central nervous system neoplasm: Although little evidence is available about the interplay between the immune system and IDH in AML, some observations have been made following extensive studies conducted on gliomas, the most common form of central nervous system neoplasm in which IDH gene mutations are recurrent [87,88,89].